Research Paper Volume 14, Issue 5 pp 2320—2334
Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma
Figure 3. PLK mutation analysis in GBM (cBioPortal). (A) Frequency of alteration in each query in the detailed cancer types. (B) Overview of genetic alteration per sample in each query gene. (C) Explore clinical sample type comparisons among groups of samples as defined by the query.